WASHINGTON — The U.S. Food & Drug Administration has approved the first adjuvanted vaccine for the prevention of H5N1 influenza, commonly known as avian or bird flu.
The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, is for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus.
Avian influenza is an infectious disease of birds caused by certain influenza A viruses. Most avian influenza A viruses do not infect people. However some viruses, such as H5N1, have caused serious illness and death in people outside of the U. . .